Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine

Completed

Conditions studied: Pertussis

In brief

To further characterize the vaccine safety profile and to identify any signals of potentially vaccine-related adverse events (AEs) not detected during pre-licensure studies.

Key facts

Study ID

NCT00258882

Run by

Sanofi Pasteur, a Sanofi Company

People needed

327293

Starts

2006-01-01

Expected to finish

2012-12-01

Last updated by the study team

2018-07-17

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Receipt of ADACEL vaccine during the study period

You may not qualify if…

• None

Where it is running

• Study site — Oakland, California, United States
• Study site — Aurora, Colorado, United States
• Study site — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.